Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study.
Yan, S., Appleby, T., Larson, G., Wu, J.Z., Hamatake, R.K., Hong, Z., Yao, N.(2007) Bioorg Med Chem Lett 17: 1991-1995
- PubMed: 17276060 
- DOI: 10.1016/j.bmcl.2007.01.024
- Primary Citation of Related Structures:  
2O5D - PubMed Abstract: 
A novel series of thiazolone-acylsulfonamides were designed as HCV NS5B polymerase allosteric inhibitors. The structure based drug designs (SBDD) were guided by docking results that revealed the potential to explore an additional pocket in the allosteric site ...